课题基金 / 基金详情

Innovative use of hydrogel technology to recapitulate and investigate cardiac pathology.

Innovative use of hydrogel technology to recapitulate and investigate cardiac pathology.
创新地使用水凝胶技术来概括和研究心脏病理学。
批准号:
nhmrc : GNT1143203
负责人:
Dr Helena Viola
金额:
$71.62万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 --

项目摘要

项目成果

Dr Helena Viola的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hypertrophic cardiomyopathy is the leading cause of sudden death in the young. No treatment exists that can reverse or prevent it, primarily because the underlying mechanisms of the disease have not been fully elucidated. I will use innovative hydrogel technology to simulate the disease state. I will use this as a tool to identify the mechanisms involved with development of the disease. This will enable identification of potential therapeutic targets for prevention of the disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innovative use of hydrogel technology to recapitulate and investigate cardiac pathology.
  • 批准号:
    nhmrc : 1143203
  • 项目类别:
    Project Grants
  • 资助金额:
    $48.42万
  • 财政年份:
    2018
  • 负责人:
    Dr Helena Viola
  • 依托单位:
How does the mitochondria regulate cardiac L-type Ca2+ channel function?
  • 批准号:
    nhmrc : 463921
  • 项目类别:
    NHMRC Postgraduate Scholarships
  • 资助金额:
    $5.32万
  • 财政年份:
    2007
  • 负责人:
    Dr Helena Viola
  • 依托单位:
国内基金
海外基金
降低慢病毒载体转录“通读率”的研究
  • 批准号:
    81271690
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2012
  • 负责人:
    张敬之
  • 依托单位: